Psychotic Agitation in a Patient with COVID-19: Pathogenesis or Iatrogenesis?

Psychotic Agitation in a Patient with COVID-19: Pathogenesis or Iatrogenesis?

Bibliographic Details
Main Authors:	Umit Haluk Yesilkaya, Yasin Hasan Balcioglu, Meltem Sen
Format:	Article
Language:	English
Published:	AVES 2021-06-01
Series:	Psychiatry and Clinical Psychopharmacology
Online Access:	https://psychiatry-psychopharmacology.com/en/psychotic-agitation-in-a-patient-with-covid-19-pathogenesis-or-iatrogenesis-133108

Similar Items

Psychotic symptoms in the context of levodopa treatment in Parkinson’s Disease: clinical feature or iatrogenesis?
by: M.L. Costa, et al.
Published: (2022-06-01)

Duodenal perforation in a patient with heroin use
by: Ümit Haluk Yesilkaya, et al.
Published: (2019-02-01)

THE JOURNEY TO THE LAND IATROGENESIS
by: L. I. Dvoretsky
Published: (2017-03-01)

Iatrogenesis in the Intensive Care
by: Oksana I. Kosukhina, et al.
Published: (2018-12-01)

Understanding and Responding to ‘Iatrogenesis’
by: Digvijay S. Timilsina
Published: (2005-01-01)

Iatrogenesis in mental health care
by: M. Sánchez Revuelta, et al.
Published: (2021-04-01)

LAND OR PEOPLE? ON THE IATROGENESIS OF CONFLATION
by: Mirek Dymitrow, et al.
Published: (2016-07-01)

ETIOPATHOGENESIS OF FACIAL PARALYSIS. IATROGENESIS IN THE DENTAL OFFICE
by: Aranka Ilea, et al.
Published: (2014-07-01)

Iatrogenesis as a possible cause of chronification of mental disorders
by: C. Martín Villarroel, et al.
Published: (2021-04-01)

Connecting the DOTS: Spectre of a public health iatrogenesis?
by: Rajib Dasgupta, et al.
Published: (2012-01-01)

Iatrogenesis: A review on nature, extent, and distribution of healthcare hazards
by: Rafia Farooq Peer, et al.
Published: (2018-01-01)

Drug therapy, potential interactions and iatrogenesis as factors related to frailty in the elderly
by: Andressa Rodrigues Pagno, et al.
Published: (2018-10-01)

Factors related to the occurrence of iatrogenesis in elderly patients hospitalized in a geriatric ward: a prospective study
by: Claudia Szlejf, et al.
Published: (2008-09-01)

Management of Agitation During the COVID-19 Pandemic
by: Ambrose H. Wong, et al.
Published: (2020-07-01)

Agitation and Agitators
by: M. Zarei Abyaneh
Published: (1991-05-01)

COVID 19 pandemic and psychotic symptoms
by: Umut Kırlı, et al.
Published: (2020-10-01)

Covid 19, lockdown and brief psychotic disorders
by: J. Gonçalves Cerejeira, et al.
Published: (2021-04-01)

Psychotic Process in the COVID-19 Pandemic: Dopamine Effect
by: Ayşegül Dönmez, et al.
Published: (2024-06-01)

Persistent psychotic symptoms following COVID-19 infection
by: Soon Tjin Lim, et al.
Published: (2020-09-01)

COVID-19 pandemic and distinct patterns of psychotic outbreaks
by: Carlos Gustavo Costardi, et al.
Published: (2021-05-01)

Psychotic relapse from COVID-19 pandemic: Clinical features
by: L. Brahmi, et al.
Published: (2021-04-01)

The agitated patient on the neurology ward
by: Killian Welch
Published: (2016-02-01)

Psychosomatic regularities of psychotic disorders of women in involution (pathogenesis, clinics, psychodynamic psychotherapy)
by: М. М. Pustovoyt
Published: (2017-08-01)

Effect of Agitator’s Types on the Hydrodynamic Flow in an Agitated Tank
by: Mohammed Foukrach, et al.
Published: (2020-05-01)

A case of Co-infection COVID-19 and influenza with psychotic symptoms
by: Maryam Valikhani, et al.
Published: (2023-04-01)

Insight and psychotic experiences in patients with non-psychotic depression (eng)
by: Oğuzhan Herdi, et al.
Published: (2021-09-01)

EXTENSIVE MI WITH AGITATION IN A PATIENT
by: Alireza Esmaeili, et al.
Published: (2016-03-01)

First psychotic episode, related to COVID‐19 pandemic, in a patient with tuberous sclerosis complex
by: Lina Brahmi, et al.
Published: (2021-09-01)

Agitation and addition/
by: 191980 White, Doug, et al.
Published: (1982)

The impact of the COVID-19 pandemic on the development of acute and transient psychotic disorders
by: A. Pérez-Balaguer, et al.
Published: (2021-04-01)

Covid -19 pandemic‘s impact on the clinical presentation of brief psychotic disorders
by: S. Khouadja, et al.
Published: (2022-06-01)

The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
by: A. Elias De Sousa, et al.
Published: (2022-06-01)

Psychodynamic Perspective on Psychotic Disorders and the Function of Art in Psychotherapy with Psychotic Patients
by: Aslı Sarandöl
Published: (2021-12-01)

Comparison of Neurological Soft Signs between Psychotic and Non Psychotic Patients
by: Abdollah Farhadi Nasab, et al.
Published: (2017-06-01)

The Arabic Questionnaire for Psychotic Experiences in patients with psychotic disorders: a clinical validation
by: Arij Yehya, et al.
Published: (2023-03-01)

Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department: A cross-sectional study.
by: Jeanette Brun Larsen, et al.
Published: (2019-01-01)

Methodological drawbacks of peripheral inflammatory marker studies in bipolar disorder: comment on article by Ekinci and Erkan Ekinci (eng)
by: Simge Seren Kirlioglu Balcioglu, et al.
Published: (2021-02-01)

How challenging is to manage agitated patients?
by: Daniel A. Cavalcante, et al.

First-Time Psychotic Symptoms in a Patient After COVID-19 Infection—A Case Report
by: Kacper Łoś, et al.
Published: (2021-10-01)

Episodes of aggression and psychomotor agitation in psychiatric inpatients during the period of Covid-19 pandemia
by: F. Franza, et al.
Published: (2023-03-01)